Paroxetine tablets and capsules

A method to prepare a formulation of paroxetine hydrochloride suitable for tabletting and encapsulation which method comprises sizing a dried mixture of (a) at least one filler and (b) an aqueous solution comprising paroxetine hydrochloride at a concentration of at least 150 mg/ml and a combination of an acidulant and a water dispersible polymer, said combination present in an amount effective to solubilize sufficient paroxetine hydrochloride to include an adequate dose of paroxetine hydrochloride with an amount of filler suitable for encapsulation or tabletting.